www.painphysicianjournal.com electrode tip temperature exceeding the temperature of 42°C, thus prevents damage to the target nerve (18) (19) (20) . The PRF action mechanism is not completely understood, but it involves structural rearrangement of axonal membrane proteins, modification of gene expression and modulation of inflammatory responses (18) (19) (20) .
Chye et al (21) compared PRF application on femoral and obturator nerves versus conservative management in 29 patients and reported significantly lower pain and disability scores in the PRF group at every point until the end of their 12 week follow-up period. They also found less medication requirement in the PRF group. However, this study has important selection bias because patients were divided into 2 groups according to consent or refusal to undergo PRF procedure, meaning that patients treated with PRF were more motivated and prone to report better outcome than those treated conservatively.
PRF application for HJ pain has been described only in one more study, a case report of 2 patients who showed a positive outcome 4 months after procedure (22) . In our pain management unit, we routinely use PRF for HJ pain in patients resistant to conservative treatment. We report our experience with PRF application on femoral and obturator nerves to assessing the efficacy and durability of this procedure, with followup extended up to 12 months.
SETTING
Pain management unit of an Italian Public Health Service Hospital.
METHODS

Retrospective Study
We included 14 consecutive patients with chronic (duration of more than 6 months) HJ pain not responding to conservative treatment. All patients gave written consent to report their data in a study. Institutional Review Board approved our study.
Diagnosis of HJ pain was made after clinical examination (pain in the hip region worsened by walking, inability to sleep on the affected side, positivity of HJ stress maneuvers), and radiological evaluation of the joint using the Kellgren-Lawrence HJ arthritis radiological classification (Table 1) (23, 24) . Conservative management consisted of paracetamol, nonsteroidal antiinflammatory drugs (NSAIDs) (ibuprofen or etoricoxib), and/or opiates (oxycodone/naloxone or tapentadol) in various dosages.
H H
ip joint (HJ) pain from osteoarthritis is a common condition with an overall prevalence of 11% in the general population (1). This condition is often seen in patients with multiple comorbid ities. Often, surgery is not an option and conventional drugs have either too many side effects or are ineffective. Conservative management involves both pharmacological and nonpharmacological treatment (1, 2) . HJ innervation is provided by articular branches of the femoral, obturator, and sciatic nerves (3). The anterior part of the joint is innervated by branches of the femoral and obturator nerves while branches from the sciatic nerve provide innervation to the posterior part of the joint capsule (3). Obturator and femoral articular branches are easily accessible with the use of relatively constant fluoroscopic markers. Articular branches from the sciatic (via the superior gluteal nerve) are more variable and deeper so they are not routinely used for the neural blockade.
Yavuz et al (4) reported significant pain relief lasting for 3 months after injecting local anesthetic and a steroid near articular branches of the obturator and femoral nerve. These results are similar to those obtained by Flanagan with the intraarticular injection of anesthetic and steroid (5) . However, this approach can give only short-term pain relief and repeated intraarticular steroid injections could lead to articular damage (6) .
Radiofrequency (RF) application to those target nerves is a possible way to obtain longer pain relief. RF is a neurolytic technique that uses heat to produce controlled tissue destruction (thermocoagulation). The electrode tip is usually placed near the target nerve. A high frequency continuous electrical current (usually 100 to 1000 kHz) is then passed through the electrode, which heats up the surrounding tissue creating an area of necrosis (7) (8) (9) (10) (11) (12) (13) . Tissue temperature must be raised over 50°C to enable coagulation necrosis. Lesioning of articular branches of the femoral and obturator nerves with continuous RF has been reported as effective in reducing pain from the HJ in the short time, up to 6 months (14-16). Continuous RF carries the risk of neuritis and neuroma formation (17), a safer alternative could be pulsed radiofrequency (PRF).
During PRF treatment, electrical current is delivered in short bursts at high voltage, and the generated heat dissipates between these bursts or "pulses" of treatment. In this way, PRF treatment allows for application of the same high-voltage, fluctuating electrical fields as used during conventional RF treatment, but without Patients whose pain was not controlled by pharmacological therapy were scheduled for an anesthetic test block of the articular branches of femoral and obturator nerves, which was performed under fluoroscopic guidance using the technique described by Locher (25) . Ropivacaine 0.5% 1 mL for each nerve was injected through a 22-gauge, 80 mm long spinal needle. The obturator nerve was blocked placing the tip of the needle below the inferior junction between the ischium and the pubis, which is teardrop shaped in the anteroposterior view ( Fig.1 left side) . To obtain blockade of the femoral nerve articular branch the needle tip was placed below the inferior anterior iliac spine near the anterolateral margin of the HJ ( Fig.1 right side) . Before needle positioning femoral artery was identified by palpation and needle was inserted 2 cm laterally to the pulsation to minimize the risk of accidental puncturing.
Patients were contacted the day after the test block and if they reported at least 50% pain relief after the procedure they were scheduled for PRF. A small volume of local anesthetic was used to reduce the possibility of medication spread inside the joint capsule because this would have created a false positive response to injection. One patient did not report significant pain relief after the test block and was not proposed PRF treatment. All patients gave consent to the PRF procedure.
PRF Procedure Description
Patients were awake or lightly sedated, after sterile draping, skin was numbed using 2% lidocaine, an 18-gauge, 100 mm RF needle with 10 mm active tip was positioned under fluoroscopic guidance using anatomical landmarks as described by Locher ( Fig. 1) (25) . Needle positioning technique was the same as used for the anesthetic test block. After correct positioning, sensory stimulation at 50 Hz was performed to elicit paresthesias or pain sensation in the HJ by the patient at 0.5 V. Two Hz stimulation was then performed to www.painphysicianjournal.com exclude the involvement of motor fibers. PRF was then applied to the target nerves for 300 seconds each, tip temperature was limited to 42°C. Ropivacaine 0.1% and methylprednisolone 20 mg, 2 mL were injected on the target nerves after the procedure to reduce the risk of neuritis and to alleviate procedure related pain. A compressive bandage to the needle entry zone was applied for 4 hours after the procedure to every patient to reduce the risk of hematoma formation in case of accidental puncturing of a major femoral vessel, patients were monitored for cardiovascular stability, hematoma formation, neurological deficits in the lower limbs and then sent home. Patients were instructed to continue or stop their pain medications as needed.
Study Outcomes
Patient-reported results for pain and physical function were noted as the primary outcomes of this study. The numerical rating scale (NRS) (NRS; range = 0 to 10 points; 0 = "no pain" and 10 = "worst pain") (26,27) was used to assess pain. The RF procedure was considered a "treatment success" if the patient reported a follow-up NRS score relative to the respective baseline score that was reduced by ≥ 50% (28) . The Oxford Hip Score (OHS) scale (OHS; scale = 0 to 60; 0 = "severe hip arthritis" and 60 = "satisfactory joint function") was used to assess the extent of disability associated with hip pain (29) . Patients were contacted for follow-up visits with the physician at 1, 3, 6, and 12 months after the procedure. Procedure-related adverse events such as puncturing of vessels, neuritis, or significant pain after the procedure were recorded.
Statistical Measures
Means and standard deviations (SD) were calculated for continuous demographic and primary outcome data and, after the normal distribution was assessed by the Kolmogorov-Smirnov test, means were compared by the student t test for with P ≤ 0.01 indicating significant differences. Demographic categorical data (e.g., gender) are expressed as a number of patients in the study group. Kellgren-Lawrence HJ arthritis radiological classification is reported in Table 1 as a 5-point scale where 0 is no visible radiological signs of arthritis and 4 is severe HJ arthritis with marked joint space reduction on the radiological examination (23, 24) . Outcome categorical data (i.e., sub-groups defined by treatment success) are reported as percentages, followed by confidence intervals calculated at the 95% level.
RESULTS
All of the 14 patients included reached 12 month follow-up. Demographic data of our population are reported in Table 2 . Mean NRS and OHS at different followups are reported in Table 3 and showed graphically in Figs. 2 and 3 . The difference in NRS scores from baseline was statistically significant (P < 0.01) at every follow-up. At 12 months mean NRS score was 5.8 ± 2.4, therefore one year after procedure patients still experienced significantly less pain compared to baseline. Treatment successes (i.e., ≥ 50% reduction in NRS score at follow-up) (30) were achieved in the majority (9 out of 14 patients representing 64% of the study population) of patients 1 month after the procedure as shown in Fig. 4 .
Regarding functional status, OHS improved significantly after treatment at 1, 3, and 6 months follow-up. At 12 month follow-up, OHS score was still slightly improved from basal, but this difference did not reach statistical significance (OHS at 12 months 23.3 ± 12.7 P = 0.1). A study measure of RF denervation durability was the maintenance of a patient's treatment success status (defined as a reduction in NRS of at least 50% from baseline) from 1 to 12 month follow-up (28) . Thus of 9 patients who were treated successfully at 1 month, 5 maintained this status at 6 months, and only 3 were still in this subgroup 12 months after the procedure (Fig. 4) . These findings suggest that patients that immediately benefit from the procedure will likely maintain a good pain relief in the medium term, but return near baseline NRS scores after 1 year.
We did not report any significant complication, femoral artery puncture was reported in 2 patients and was treated with a compressive bandage. In these patients, we did not observe hematomas or other significant complications after a puncture. One patient complained of loss of sensation in the medial region of the thigh for 10 hours, the normal perception was resumed after 24 hours without any other neurological deficit. 
DISCUSSION
PRF and continuous RF denervation are common procedures to reduce pain arising from peripheral joints or from vertebral structures. Despite its wide application on peripheral joints, there are only a few studies reporting outcomes, the majority of which are case reports or very limited case series.
Application of PRF to the articular nerves is an attractive strategy to reduce pain and disability in patients awaiting joint replacement or who cannot undergo surgery because of the presence of comorbidities, or who are not willing to have surgery.
The first reports of PRF application on the HJ showed promising results, with patients reporting a significant reduction of pain in the short-term (up to 3 months) when compared to a standard conservative treatment (21, 22) . Our study is the first reporting outcome at more than 3 month follow-up. Cumulative data suggest a good pain and disability reduction with the application of PRF, mean NRS and OHS were significantly lower than basal at all follow-ups. However, When mean values of a study group are used to express treatment outcomes, such treatments are significantly effective if all patients consistently benefit to some degree, or if a substantial majority of patients benefit to at least a moderate degree. Therefore, study group means indicating no statistical significance can result from relatively poor responses derived from a majority fraction of the group and can mask highly favorable responses within a minority fraction (30) . We addressed these caveats by providing categorical data for pain (NRS) in Fig. 4 , and individual data plots of these outcomes for each patient in Fig. 5 , to complement the display of pain mean outcome in Fig. 2 .
The majority (64%) of patients we treated reported a successful outcome and most of them (5 out of 9 patients considered successful 1 month after the procedure) maintained pain relief and disability reduction over time. These results suggest that a key point when proposing PRF treatment is to know which patients could benefit from the procedure. Assessing patients' characteristics associated with positive outcomes was not one of our endpoints; moreover, our population prevents us from reaching definitive conclusions. Safety is a crucial requirement of interventional procedures for pain management, one of the potential risks of HJ PRF is puncturing a major vascular structure such as the femoral vessels. In our case series, we reported only 2 cases of femoral artery puncture during needle placement. In these patients, the procedure was carried out after needle repositioning and, as for all patients, a compressive bandage was applied for 4 hours and patients were discharged only after removal of the bandage and confirmation that no blood was spilling from needle insertion point. Both patients recovered normally and there was no sign of haematoma or other significant complications. Using ultrasound assistance combined with fluoroscopy during needle placement (that we do not use routinely and was never used in our population) could be useful for further risk reduction of the vascular puncture (31) .
Limitations
Small population size, lack of a control group.
CONCLUSIONS
PRF appears to be a safe and effective technique to treat chronic hip pain. Our results suggest that patients could get significant pain relief lasting for at least 6 months. Further investigation is needed to confirm PRF efficacy in a randomized clinical trial comparing PRF to another conservative treatment such as repeated articular injections as well as to placebo.
